Fujii S, Kobayashi S, Chang Y, Nawata J, et al. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure. J Mol Cell Cardiol 2023 Mar 22:S0022-2828(23)00052.
PMID: 36963751